An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (AZD0530)
Ruby Yun‐Ju Huang(National University of Singapore), Jean Paul Thiery(Agency for Science, Technology and Research)
Cited by 467
Related Papers
GRHL2-miR-200-ZEB1 maintains the epithelial status of ovarian cancer through transcriptional regulation and histone modification
|Scientific Reports|2016|163
Short-term expansion of breast circulating cancer cells predicts response to anti-cancer therapy
|Oncotarget|2015|148
The role of GRHL2 and epigenetic remodeling in epithelial–mesenchymal plasticity in ovarian cancer cells
|Communications Biology|2019|101